Search - tctmd.com

Displaying 1 - 20 of 94

Sort: Relevancy | Date

Presentation TCT 2016

Case Conclusion: How Did I Treat?

Presenter: Runlin Gao, Bo Xu, Junjie Zhang

November 01, 2016

Presentation TCT 2016

How Would I Treat? (Option 2)

Presenter: Runlin Gao, Bo Xu, Qi Zhang

November 01, 2016

Presentation TCT 2016

How Would I Treat? (Option 1)

Presenter: Runlin Gao, Bo Xu, Jian Liu

November 01, 2016

Presentation TCT 2016

Case Introduction: How Should I Treat?

Presenter: Runlin Gao, Bo Xu, Junjie Zhang

November 01, 2016

Presentation TCT 2016

Case Conclusion: How Did I Treat?

Presenter: Runlin Gao, Bo Xu, Kefei Dou

November 01, 2016

Presentation TCT 2016

How Would I Treat? (Option 2)

Presenter: Runlin Gao, Bo Xu, Zening Jin

November 01, 2016

Presentation TCT 2016

How Would I Treat? (Option 1)

Presenter: Runlin Gao, Bo Xu, Philippe Généreux

November 01, 2016

Presentation TCT 2016

Case Introduction: How Should I Treat?

Presenter: Runlin Gao, Bo Xu, Kefei Dou

November 01, 2016

Presentation TCT 2016

TCT 548: Relationship Between Residual SYNTAX Score, Grayscale and Virtual Histology-IVUS Findings, and Non-Culprit Lesion-Related Major Adverse Cardiac Events: The PROSPECT Study

Presenter: Eric Boersma, James E. Muller

November 01, 2016

Presentation TCT 2016

SYNTAX Stratified NOBLE Results

Presenter: Evald H. Christiansen, Per Hostrup Nielsen, Ian Menown

October 31, 2016

Presentation TCT 2016

Site-reported vs Core Lab Syntax Scores: Discordance and Impact on Outcomes After PCI vs CABG in EXCEL

Presenter: A. Pieter Kappetein, Marie-Claude Morice, Philippe Généreux

October 31, 2016

Presentation TCT 2016

TCT 67: Impact of the SYNTAX Score in Patients With Diabetes and Left-Main and/or Multivessel Coronary Disease: A Pooled Analysis of Individual Patient Level Data From the SYNTAX, PRECOMBAT and BEST Trials

Presenter: Sorin J. Brener, Jean-François Tanguay, Rafael Cavalcante

October 31, 2016

Presentation TCT 2016

TCT 4: The Impact of Residual Syntax Score in Octogenarian ACS Patients

Presenter: Andreas Baumbach, Kurt Huber, Seiichi Hiramori

October 31, 2016

Presentation TCT 2016

TCT 140: Explore Trial (Additional Early CTO PCI in STEMI Patients with a Concurrent CTO) and SYNTAX score. What are Lessons Learned?

Presenter: Warren J. Cantor, Thomas D. Stuckey

October 30, 2016

Presentation TCT 2016

Mortality of Stenting vs Bypass Surgery According to Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of SYNTAX, PRECOMBAT, and BEST Trials

Presenter: Jung-Min Ahn

October 30, 2016

Presentation TCT 2016

Value and Hazards of Subgroup Analysis: the SYNTAX to EXCEL Case Study

Presenter: Peter Juni, E. Magnus Ohman, Ori Ben-Yehuda

October 30, 2016

Presentation TCT 2016

Have Contemporary DES Narrowed the Gap With CABG in Multivessel Disease? From BEST to SYNTAX II and Beyond

Presenter: Dean J. Kereiakes, Pieter C. Smits, Patrick W. Serruys

October 30, 2016

Presentation TCT 2015

PCI vs CABG for LM Disease: New Insights From Syntax LM to Help Choose

Presenter: Davide Capodanno, Gregg W. Stone, Patrick W. Serruys

October 15, 2015

Presentation TCT 2015

Case Presentation: How We Treated MVD With LV Dysfunction With Intermediate SYNTAX Score

Presenter: Robert O. Bonow, Ajay J. Kirtane, Adriano Caixeta

October 14, 2015

Presentation TCT 2015

Case Presentation at Baseline: MVD With LV Dysfunction With Intermediate SYNTAX Score

Presenter: Robert O. Bonow, Ajay J. Kirtane, Adriano Caixeta

October 14, 2015

Advertisement

Case Conclusion: How Did I Treat?

How Would I Treat? (Option 2)

How Would I Treat? (Option 1)

Case Introduction: How Should I Treat?

Case Conclusion: How Did I Treat?

How Would I Treat? (Option 2)

How Would I Treat? (Option 1)

Case Introduction: How Should I Treat?

TCT 548: Relationship Between Residual SYNTAX Score, Grayscale and Virtual Histology-IVUS Findings, and Non-Culprit Lesion-Related Major Adverse Cardiac Events: The PROSPECT Study

SYNTAX Stratified NOBLE Results

Site-reported vs Core Lab Syntax Scores: Discordance and Impact on Outcomes After PCI vs CABG in EXCEL

TCT 67: Impact of the SYNTAX Score in Patients With Diabetes and Left-Main and/or Multivessel Coronary Disease: A Pooled Analysis of Individual Patient Level Data From the SYNTAX, PRECOMBAT and BEST Trials

TCT 4: The Impact of Residual Syntax Score in Octogenarian ACS Patients

TCT 140: Explore Trial (Additional Early CTO PCI in STEMI Patients with a Concurrent CTO) and SYNTAX score. What are Lessons Learned?

Mortality of Stenting vs Bypass Surgery According to Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of SYNTAX, PRECOMBAT, and BEST Trials

Value and Hazards of Subgroup Analysis: the SYNTAX to EXCEL Case Study

Have Contemporary DES Narrowed the Gap With CABG in Multivessel Disease? From BEST to SYNTAX II and Beyond

PCI vs CABG for LM Disease: New Insights From Syntax LM to Help Choose

Case Presentation: How We Treated MVD With LV Dysfunction With Intermediate SYNTAX Score

Case Presentation at Baseline: MVD With LV Dysfunction With Intermediate SYNTAX Score

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content